PTCT News
Archived Headlines
- US IPO Recap: Textura and LightInTheBox gain over 30%, eight companies file 06/10/13
- PTC Therapeutics sets terms for $100 million IPO 06/05/13
- US IPO Recap: Marketo and Tableau soar, May calendar stays full 05/20/13
- PTC Therapeutics files for a $85 million IPO following failed IPO attempt in 2006 05/16/13
- Biotech PTC Therapeutics withdraws IPO 04/20/07
See more
Cystic fibrosis biotech ProQR Therapeutics files for a $75 million IPO
ProQR Therapeutics, a dutch biotech developing mRNA treatments for cystic fibrosis, filed on Thursday with the SEC to raise up to $75 million in an initial public offering. The Leiden, Netherlands-based company, which was founded in 2012, plans to list on...read more
US IPO Recap: Biotech success continues, but three deals delayed or postponed
Three companies priced US IPOs last week, while one was delayed and two, including Votorantim Cimentos (VEBM), the largest expected deal of 2013 year-to-date, were postponed. Two biotechs, bluebird bio (BLUE) and PTC Therapeutics (PTCT), priced upsized...read more
PTC Therapeutics prices IPO at $15, within the range
PTC Therapeutics, a biotech targeting rare forms of muscular dystrophy and cystic fibrosis, raised $126 million by offering 8.4 million shares at $15.00, within the range of $13.00 to $16.00. PTC Therapeutics plans to list on the NASDAQ under the symbol PTCT....read more
6 US IPOs planned for the week of Jun 17
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for humans, plans...read more